Longitude Capital Partners Iii's Net Worth
Longitude Capital Partners Iii's net worth is estimated to be at least $49,778,507.00 as of 05/04/2024. CoreStreet's estimation of Longitude Capital Partners Iii's net worth is based on their sale of stock and current holding of stock.
Longitude Capital Partners Iii is Major Shareholder at Inozyme Pharma Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,355,000 units of INZY stock on 04/19/2022. Their biggest sale was on 08/28/2020 when they sold 3,496 units of Molecular Templates Inc stock for $37,582.00. They typically trade 2 times per year.
Total value of insider buys:
- $49,740,925.00
Total value of insider sells:
- $37,582.00
Most recent insider trade:
- April 19, 2022
Longitude Capital Partners Iii's Insider Trading History
| Inozyme Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 19, 2022 | Major Shareholder | 1,355,000 | $3.69 | Buy | $4,999,950.00 |
July 28, 2020 | Major Shareholder | 625,000 | $16.00 | Buy | $10,000,000.00 |
| Sierra Oncology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 2, 2022 | Major Shareholder | 175,000 | $27.00 | Buy | $4,725,000.00 |
| Talaris Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 11, 2021 | Major Shareholder | 235,000 | $17.00 | Buy | $3,995,000.00 |
| Molecular Templates Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 28, 2020 | Major Shareholder | 3,496 | $10.75 | Sell | $37,582.00 |
Nov. 25, 2019 | Major Shareholder | 937,000 | $8.00 | Buy | $7,496,000.00 |
| 89bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 10, 2020 | Major Shareholder | 109,090 | $27.50 | Buy | $2,999,975.00 |
Nov. 11, 2019 | Major Shareholder | 575,000 | $27.00 | Buy | $15,525,000.00 |